U.S. Physical Therapy reports recurring developments tied to its national outpatient physical therapy clinic network and industrial injury prevention services business. Company news commonly covers physical therapy revenue, mature-clinic activity, gross profit, reimbursement-sensitive care categories, and services for orthopedic conditions, sports injuries, neurological injuries, post-operative care, preventative care, and injured-worker rehabilitation.
Updates also include acquisitions of clinic practices and industrial injury prevention businesses, hospital and regional care alliances, investor presentations, dividends, share repurchases, and credit facility changes. Its industrial injury prevention services include onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments for client workforces.
U.S. Physical Therapy (USPH) reported third-quarter 2026 revenue of $223 million, up 13% from the same quarter a year earlier. Net income attributable to shareholders fell to $11 million from $13 million, while loss per share was $1.04 versus earnings of $0.48. Adjusted EBITDA, a non-GAAP earnings measure, rose to $28 million from $24 million.
Patient visits increased 8.3% to 1,682,642, and physical therapy revenue per visit rose to $110.61 from $105.54. All 72 clinics under two hospital affiliations were integrated, generating $25 million in quarterly revenue. Higher employee health benefit costs weighed on margins. Nine-month revenue increased 10% to $635 million, but shareholder net income fell to $26 million from $35 million. Borrowings reached $247 million versus $162 million at year-end. Management reaffirmed 2026 adjusted EBITDA guidance of $102 million to $106 million.
U.S. Physical Therapy (USPH) will release its third-quarter 2026 financial results after the stock market closes on November 4, 2026. The results cover the three and nine months ended September 30, 2026. A conference call will follow on November 5, 2026, at 10:30 a.m. Eastern / 9:30 a.m. Central. The live webcast will be available through the Investor Relations section of www.usph.com, with playback available until February 3, 2027.
U.S. Physical Therapy (USPH) has appointed Myra Davis to its Board of Directors, effective October 1, 2026.
Davis is Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital and has held senior technology leadership roles there since 2003, including CIO from 2009 to 2019. She leads enterprise technology strategy, digital transformation, innovation and information services for a major pediatric healthcare system and is recognized for implementing secure, scalable technology solutions and building high-performing teams.
Davis also serves on the Board of Werfen and on the Advisory Board of the Healthcare Information Management Systems Society of America. U.S. Physical Therapy operates 799 outpatient physical therapy clinics in 45 states and provides industrial injury prevention services.
U.S. Physical Therapy (NYSE: USPH) announced that Chairman and CEO Chris Reading presented at the 17th Annual Midwest Ideas Conference on August 26, 2026. The presentation covered the healthcare operating environment, the company’s key initiatives, and an overview of growth opportunities. U.S. Physical Therapy operates 798 outpatient physical therapy clinics across 45 states and runs an industrial injury prevention business serving employer worksites.
U.S. Physical Therapy (NYSE: USPH) has appointed Nchacha Etta as Executive Vice President and Chief Financial Officer, effective September 1, 2026. He succeeds Interim CFO Jason Curtis, who has served in that role since April 24, 2026 and will continue as Senior Vice President, Finance and Accounting.
According to U.S. Physical Therapy, Etta previously held senior finance leadership roles at Omnicell, Essilor of America, Johnson & Johnson Vision, and The Coca-Cola Company, and earlier worked at Microsoft, Eli Lilly and The Carlyle Group. The company operates 796 outpatient physical therapy locations across 45 states and an industrial injury prevention business.
U.S. Physical Therapy (NYSE: USPH) reported Q2 2026 net revenue of $214.1 million, up 8.5% year over year. Net income attributable to shareholders declined to $9.9 million from $12.4 million, with GAAP EPS of $0.25 versus $0.58, reflecting dilution from redeemable noncontrolling interests. Non‑GAAP operating results were $11.3 million (vs. $12.4 million) and adjusted EBITDA was broadly flat at $27.0 million (vs. $26.9 million).
Physical therapy revenue rose 8.4% with 6.6% more patient visits and higher revenue per visit, while physical therapy margins decreased, partly due to health benefit costs. IIP revenue grew 9.1%. Management reaffirmed 2026 adjusted EBITDA guidance of $102–106 million, highlighted hospital affiliation integrations affecting 70 clinics, completed three acquisitions totaling $37.6 million in purchase price, expanded its credit facility to $450 million, repurchased $19.2 million of shares in Q2, and declared a quarterly dividend of $0.46 per share.
NACD North Texas announced its 2026–2027 slate of officers and new board members, effective July 1, 2026. Debra L. von Storch was elected board chair, with Anne Motsenbocker as vice chair, Todd Murray continuing as secretary, and Derek McClain serving as treasurer.
New board members are Beth Garvey, former chair, president, and CEO of BGSF (NYSE: BGSF); Dr. Helmuth Ludwig, former Siemens Global CIO and current multi‑company director; Cassandra McKinney, independent director at Lithia & Driveway (NYSE: LAD); and Dan Torpey, senior managing director at Ankura and experienced audit and risk advisor. According to NACD North Texas, these leaders bring expertise spanning audit, compensation, governance, digital transformation, risk oversight, and membership engagement to support more than 1,000 chapter members.
U.S. Physical Therapy (NYSE: USPH) will release financial results for the three and six months ended June 30, 2026, on Wednesday, August 5, 2026, after market close. A conference call to discuss these results will be held on Thursday, August 6, 2026, at 10:30 a.m. Eastern / 9:30 a.m. Central, with phone and webcast access available to investors.
U.S. Physical Therapy (NYSE:USPH) acquired a twelve-clinic physical therapy practice effective July 1, 2026, purchasing a 67% equity interest while the current owners retain 33%.
The practice generates about 112,000 annual visits and $12 million in annual revenue, expanding USPH’s footprint from 44 to 45 states and increasing its network to 795 clinics.
U.S. Physical Therapy (NYSE:USPH)/b) announced that Chairman and CEO Chris Reading presented at the on May 13, 2026.
The presentation covered the healthcare operating environment, the company’s key initiatives, and a broad overview of growth opportunities across its outpatient clinics and industrial injury prevention services.